BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1132 related articles for article (PubMed ID: 35236323)

  • 1. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
    Xu L; Zheng Q; Liu W
    BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.
    Fang G; Zhang Q; Fan J; Li H; Ding Z; Fu J; Wu Y; Zeng Y; Liu J
    BMC Cancer; 2022 Sep; 22(1):999. PubMed ID: 36127654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.
    Deng M; Sun S; Zhao R; Guan R; Zhang Z; Li S; Wei W; Guo R
    Mol Med; 2022 Feb; 28(1):16. PubMed ID: 35123387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma.
    Wang S; Gao S; Shan L; Qian X; Luan J; Lv X
    PeerJ; 2023; 11():e14691. PubMed ID: 36650832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pyroptosis-Based Prognostic Model for Immune Microenvironment Estimation of Hepatocellular Carcinoma.
    Chen Z; Zou Y; Zhang Y; Chen Z; Wu F; Jin H; Shi N
    Dis Markers; 2022; 2022():8109771. PubMed ID: 35047095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic signature for hepatocellular carcinoma based on 4 pyroptosis-related genes.
    Duan S; Gao J; Lou W; Zhang Y; Deng Y; Wang C; Huang H; Xu H; Guo S; Lai S; Xi F; Li Z; Deng L; Zhong Y
    BMC Med Genomics; 2022 Jul; 15(1):166. PubMed ID: 35902905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.
    Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G
    Front Immunol; 2022; 13():929089. PubMed ID: 35874689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of stable ferroptosis- and pyroptosis-related signatures in predicting prognosis and immune status in breast cancer.
    Zhou L; Wong C; Liu Y; Jiang W; Yang Q
    J Cell Mol Med; 2023 Dec; 27(23):3827-3838. PubMed ID: 37849388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pyroptosis-Related Gene Signature to Predict Patients' Prognosis and Immune Landscape in Liver Hepatocellular Carcinoma.
    Wang J; Huang Z; Lu H; Zhang R; Feng Q; He A
    Comput Math Methods Med; 2022; 2022():1258480. PubMed ID: 35242200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
    Yan Z; He M; He L; Wei L; Zhang Y
    Front Immunol; 2021; 12():723271. PubMed ID: 34925311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
    Front Immunol; 2021; 12():719175. PubMed ID: 34603293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma.
    Liu Z; Wang J; Li S; Li L; Li L; Li D; Guo H; Gao D; Liu S; Ruan C; Dang X
    Front Immunol; 2022; 13():1076045. PubMed ID: 36591279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic values of pyroptosis-related genes for the hepatocellular carcinoma.
    Xing M; Li J
    BMC Bioinformatics; 2022 May; 23(1):177. PubMed ID: 35562678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes.
    Yan J; Cao J; Chen Z
    BMC Cancer; 2021 Feb; 21(1):175. PubMed ID: 33602168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma.
    Zhou J; Wang X; Li Z; Jiang R
    FEBS Open Bio; 2021 Nov; 11(11):3005-3018. PubMed ID: 34499810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes].
    Rong HC; Zhao WF; Zheng N; Guo ZH; Wang YW; Huang XP
    Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):509-517. PubMed ID: 37365028
    [No Abstract]   [Full Text] [Related]  

  • 18. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.
    Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L
    World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and in vitro and in vivo validation of the key role of GSDME in pyroptosis-related genes signature in hepatocellular carcinoma.
    Chen X; Yang M; Wang L; Wang Y; Tu J; Zhou X; Yuan X
    BMC Cancer; 2023 May; 23(1):411. PubMed ID: 37149620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A scoring model based on ferroptosis genes for prognosis and immunotherapy response prediction and tumor microenvironment evaluation in liver hepatocellular carcinoma.
    Gao L; Xue J; Liu X; Cao L; Wang R; Lei L
    Aging (Albany NY); 2021 Nov; 13(22):24866-24881. PubMed ID: 34839280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.